WNT5A: a motility-promoting factor in Hodgkin lymphoma

J 2017

WNT5A: a motility-promoting factor in Hodgkin lymphoma

LINKE, F., S. ZAUNIG, M.M. NIETERT, Bonin F. VON, S. LUTZ et. al.

Basic information

Original name

WNT5A: a motility-promoting factor in Hodgkin lymphoma

Authors

LINKE, F. (276 Germany), S. ZAUNIG (276 Germany), M.M. NIETERT (276 Germany), Bonin F. VON (276 Germany), S. LUTZ (276 Germany), C. DULLIN (276 Germany), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), T. BEISSBARTH (276 Germany), F. ALVES (276 Germany), W. KLAPPER (276 Germany), Vítězslav BRYJA (203 Czech Republic, guarantor, belonging to the institution), T. PUKROP (276 Germany), L. TRUMPER (276 Germany), J. WILTING (276 Germany) and D. KUBE (276 Germany)

Edition

Oncogene, London, Nature Publishing Group, 2017, 0950-9232

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 6.854

RIV identification code

RIV/00216224:14310/17:00097545

Organization unit

Faculty of Science

DOI

http://dx.doi.org/10.1038/onc.2016.183

UT WoS

000394069100002

Keywords (in Czech)

Wnt signální dráha; Hodgkinův lymphom

Keywords in English

Wnt signaling; Hodgkin lymphoma

Abstract

V originále

Classical Hodgkin lymphoma (cHL) has a typical clinical manifestation, with dissemination involving functionally neighboring lymph nodes. The factors involved in the spread of lymphoma cells are poorly understood. Here we show that cHL cell lines migrate with higher rates compared with non -Hodgkin lymphoma cell lines. cHL cell migration, invasion and adhesion depend on autocrine WNT signaling as revealed by the inhibition of WNT secretion with the porcupine inhibitors Wnt-059/IWP-2, but did not affect cell proliferation. While application of recombinant WNT5A or WNT5A overexpression stimulates cHL cell migration, neither WNT10A, WNT1OB nor WNT16 did so. Time-lapse studies revealed an amoeboid type of cell migration modulated by WNT5A. Reduced migration distances and velocity of cHL cells, as well as altered movement patterns, were observed using porcupine inhibitor or WNT5A antagonist. Knockdown of Frizzled5 and Dishevelled3 disrupted the WNT5A-mediated RHOA activation and cell migration. Overexpression of DVL3-K435M or inhibition of ROCK (Rho-associated protein kinase) by Y-27632/H1152P disrupted cHL cell migration. In addition to these mechanistic insights into the role of WNT5A in vitro, global gene expression data revealed an increased WNT5A expression in primary HL cells in comparison with normal B-cell subsets and other lymphomas. Furthermore, the activity of both porcupine and WNT5A in cHL cells had an impact on lymphoma development in the chick chorionallantoic membrane assay. Massive bleeding of these lymphomas was significantly reduced after inhibition of WNT secretion by Wnt-059. Therefore, a model is proposed where WNT signaling has an important role in regulating tumor-promoting processes.

Citovat

LINKE, F., S. ZAUNIG, M.M. NIETERT, Bonin F. VON, S. LUTZ, C. DULLIN, Pavlína JANOVSKÁ, T. BEISSBARTH, F. ALVES, W. KLAPPER, Vítězslav BRYJA, T. PUKROP, L. TRUMPER, J. WILTING and D. KUBE. WNT5A: a motility-promoting factor in Hodgkin lymphoma. Oncogene. London: Nature Publishing Group, 2017, vol. 36, No 1, p. 13-23. ISSN 0950-9232. Available from: https://dx.doi.org/10.1038/onc.2016.183.

@article{1389325,
   author = {Linke, F. and Zaunig, S. and Nietert, M.M. and von, Bonin F. and Lutz, S. and Dullin, C. and Janovská, Pavlína and Beissbarth, T. and Alves, F. and Klapper, W. and Bryja, Vítězslav and Pukrop, T. and Trumper, L. and Wilting, J. and Kube, D.},
   article_location = {London},
   article_number = {1},
   doi = {http://dx.doi.org/10.1038/onc.2016.183},
   keywords = {Wnt signaling; Hodgkin lymphoma},
   language = {eng},
   issn = {0950-9232},
   journal = {Oncogene},
   title = {WNT5A: a motility-promoting factor in Hodgkin lymphoma},
   volume = {36},
   year = {2017}
}

TY  - JOUR
ID  - 1389325
AU  - Linke, F. - Zaunig, S. - Nietert, M.M. - von, Bonin F. - Lutz, S. - Dullin, C. - Janovská, Pavlína - Beissbarth, T. - Alves, F. - Klapper, W. - Bryja, Vítězslav - Pukrop, T. - Trumper, L. - Wilting, J. - Kube, D.
PY  - 2017
TI  - WNT5A: a motility-promoting factor in Hodgkin lymphoma
JF  - Oncogene
VL  - 36
IS  - 1
SP  - 13-23
EP  - 13-23
PB  - Nature Publishing Group
SN  - 09509232
KW  - Wnt signaling
KW  - Hodgkin lymphoma
N2  - Classical Hodgkin lymphoma (cHL) has a typical clinical manifestation, with dissemination involving functionally neighboring lymph nodes. The factors involved in the spread of lymphoma cells are poorly understood. Here we show that cHL cell lines migrate with higher rates compared with non -Hodgkin lymphoma cell lines. cHL cell migration, invasion and adhesion depend on autocrine WNT signaling as revealed by the inhibition of WNT secretion with the porcupine inhibitors Wnt-059/IWP-2, but did not affect cell proliferation. While application of recombinant WNT5A or WNT5A overexpression stimulates cHL cell migration, neither WNT10A, WNT1OB nor WNT16 did so. Time-lapse studies revealed an amoeboid type of cell migration modulated by WNT5A. Reduced migration distances and velocity of cHL cells, as well as altered movement patterns, were observed using porcupine inhibitor or WNT5A antagonist. Knockdown of Frizzled5 and Dishevelled3 disrupted the WNT5A-mediated RHOA activation and cell migration. Overexpression of DVL3-K435M or inhibition of ROCK (Rho-associated protein kinase) by Y-27632/H1152P disrupted cHL cell migration. In addition to these mechanistic insights into the role of WNT5A in vitro, global gene expression data revealed an increased WNT5A expression in primary HL cells in comparison with normal B-cell subsets and other lymphomas. Furthermore, the activity of both porcupine and WNT5A in cHL cells had an impact on lymphoma development in the chick chorionallantoic membrane assay. Massive bleeding of these lymphomas was significantly reduced after inhibition of WNT secretion by Wnt-059. Therefore, a model is proposed where WNT signaling has an important role in regulating tumor-promoting processes.
ER  -

LINKE, F., S. ZAUNIG, M.M. NIETERT, Bonin F. VON, S. LUTZ, C. DULLIN, Pavlína JANOVSKÁ, T. BEISSBARTH, F. ALVES, W. KLAPPER, Vítězslav BRYJA, T. PUKROP, L. TRUMPER, J. WILTING and D. KUBE. WNT5A: a motility-promoting factor in Hodgkin lymphoma. \textit{Oncogene}. London: Nature Publishing Group, 2017, vol.~36, No~1, p.~13-23. ISSN~0950-9232. Available from: https://dx.doi.org/10.1038/onc.2016.183.

Detailed Information on Publication Record